GlassScriptPhysician profile
Jonathan David Dickson
NPI 1487110474
$1,771.23
in general payments reported to CMS, 2019-2025
14 companies · $867 in 2025
The $867 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $142 · 2023: $266 · 2024: $395 · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.40 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $398.00 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $347.36 | 2023-2025 | Winlevi, Absorica Ld, Odomzo |
| Novartis Pharmaceuticals Corporation | $248.74 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $208.49 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $162.25 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $88.51 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Genzyme Corporation | $74.55 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $65.87 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $47.21 | 2023-2024 | Dupixent |
| Incyte Corporation | $35.84 | 2023-2025 | Opzelura |
| Inari Medical, INC. | $34.36 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.25 | 2025 | Jublia, Siliq, Cabtreo |
| Janssen Biotech, INC. | $18.44 | 2024 | Tremfya |
| Pfizer INC. | $17.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.